363 related articles for article (PubMed ID: 29859325)
1. Activation of Akt by SC79 decreased cerebral infarct in early cerebral ischemia-reperfusion despite increased BBB disruption.
Liu X; Kiss GK; Mellender SJ; Weiss HR; Chi OZ
Neurosci Lett; 2018 Aug; 681():78-82. PubMed ID: 29859325
[TBL] [Abstract][Full Text] [Related]
2. SC79, the AKT Activator Protects Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury.
Luan Q; Pan L; He D; Gong X; Zhou H
Med Sci Monit; 2018 Aug; 24():5391-5397. PubMed ID: 30074018
[TBL] [Abstract][Full Text] [Related]
3. Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion.
Chi OZ; Mellender SJ; Barsoum S; Liu X; Damito S; Weiss HR
Neurosci Lett; 2016 May; 620():132-6. PubMed ID: 27037216
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p70 ribosomal S6 kinase 1 (S6K1) by PF-4708671 decreased infarct size in early cerebral ischemia-reperfusion with decreased BBB permeability.
Chi OZ; Kiss GK; Mellender SJ; Liu X; Liu S; Jacinto E; Weiss HR
Eur J Pharmacol; 2019 Jul; 855():202-207. PubMed ID: 31063769
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid increased infarct size in the early stage of cerebral ischemia-reperfusion with increased BBB permeability.
Chi OZ; Mellender SJ; Kiss GK; Chiricolo A; Liu X; Patel N; Jacinto E; Weiss HR
J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105029. PubMed ID: 32912542
[TBL] [Abstract][Full Text] [Related]
6. Blood -brain barrier disruption was less under isoflurane than pentobarbital anesthesia via a PI3K/Akt pathway in early cerebral ischemia.
Chi OZ; Mellender SJ; Kiss GK; Liu X; Weiss HR
Brain Res Bull; 2017 May; 131():1-6. PubMed ID: 28238830
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption.
Chi OZ; Chiricolo A; Liu X; Patel N; Jacinto E; Weiss HR
Neurosci Lett; 2021 Sep; 762():136143. PubMed ID: 34332027
[TBL] [Abstract][Full Text] [Related]
8. Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption.
Chi OZ; Liu X; Cofano S; Patel N; Jacinto E; Weiss HR
Front Physiol; 2021; 12():706528. PubMed ID: 34354602
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia.
Chi OZ; Kiss GK; Mellender SJ; Liu X; Weiss HR
Neurosci Lett; 2017 Jul; 654():17-22. PubMed ID: 28625574
[TBL] [Abstract][Full Text] [Related]
10. Akt activation improves microregional oxygen supply/consumption balance after cerebral ischemia-reperfusion.
Weiss HR; Chi OZ; Kiss GK; Liu X; Damito S; Jacinto E
Brain Res; 2018 Mar; 1683():48-54. PubMed ID: 29371097
[TBL] [Abstract][Full Text] [Related]
11. Adhesion molecule L1 inhibition increases infarct size in cerebral ischemia-reperfusion without change in blood-brain barrier disruption.
Chi OZ; Theis T; Kumar S; Chiricolo A; Liu X; Farooq S; Trivedi N; Young W; Schachner M; Weiss HR
Neurol Res; 2021 Sep; 43(9):751-759. PubMed ID: 34057049
[TBL] [Abstract][Full Text] [Related]
12. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats.
Yu ZH; Cai M; Xiang J; Zhang ZN; Zhang JS; Song XL; Zhang W; Bao J; Li WW; Cai DF
J Ethnopharmacol; 2016 Apr; 181():8-19. PubMed ID: 26805466
[TBL] [Abstract][Full Text] [Related]
13. Leucine Reduced Blood-Brain Barrier Disruption and Infarct Size in Early Cerebral Ischemia-Reperfusion.
Chi OZ; Liu X; Magsino J; Weiss HR
Brain Sci; 2023 Sep; 13(10):. PubMed ID: 37891741
[TBL] [Abstract][Full Text] [Related]
14. Anesthesia-Induced Hypothermia Attenuates Early-Phase Blood-Brain Barrier Disruption but Not Infarct Volume following Cerebral Ischemia.
Liu YC; Lee YD; Wang HL; Liao KH; Chen KB; Poon KS; Pan YL; Lai TW
PLoS One; 2017; 12(1):e0170682. PubMed ID: 28118390
[TBL] [Abstract][Full Text] [Related]
15. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
Chi OZ; Hunter C; Liu X; Weiss HR
Neurol Res; 2005 Dec; 27(8):864-8. PubMed ID: 16354548
[TBL] [Abstract][Full Text] [Related]
16. The relationship between erythropoietin pretreatment with blood-brain barrier and lipid peroxidation after ischemia/reperfusion in rats.
Bahcekapili N; Uzüm G; Gökkusu C; Kuru A; Ziylan YZ
Life Sci; 2007 Mar; 80(14):1245-51. PubMed ID: 17300815
[TBL] [Abstract][Full Text] [Related]
17. Endogenous FGF21 attenuates blood-brain barrier disruption in penumbra after delayed recanalization in MCAO rats through FGFR1/PI3K/Akt pathway.
Zheng W; Li W; Zeng Y; Yuan H; Yang H; Chen R; Zhu A; Wu J; Song Z; Yan W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):648-662. PubMed ID: 37539567
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic Preconditioning Increases Blood-Brain Barrier Disruption in the Early Stages of Cerebral Ischemia.
Chi OZ; Mellender SJ; Barsoum S; Liu X; Weiss HR
Curr Neurovasc Res; 2017; 14(1):26-31. PubMed ID: 27823555
[TBL] [Abstract][Full Text] [Related]
20. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
